Companies /Technology

Ichor Holdings Ltd

NASDAQ: ICHR Semiconductor Equipment & Materials
$60.87
▼ $1.57 (−2.51%) today
Markets closed · 4:49pm ET

24/7 Wall St. View

ICHR at a Glance

Valuation
Market cap
$2.4B
Profitability
Revenue (TTM)
$1.0B
Profit margin
-4.0%
EPS (TTM)
$-1.17
Price
52-week range
$14 – $114
Street target
$95.86
Earnings
Next report
Nov 3, 2026
Q2 2026 EPS
$0.34
vs. $0.31 est.
+10.7%

Headquartered in Fremont, CA Fiscal year ends December NASDAQ: ICHR ichorsystems.com

About Ichor Holdings

Ichor Holdings, Ltd. (NASDAQ: ICHR) designs, engineers, and manufactures critical fluid delivery subsystems and components primarily for semiconductor capital equipment, with additional exposure to defense/aerospace and medical industries. Its primary product offerings include gas delivery subsystems that deliver, monitor, and control specialized gases used in semiconductor manufacturing processes such as etch and deposition, and chemical delivery subsystems that blend and dispense reactive liquid chemistries used in processes like chemical-mechanical planarization, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser welded components, precision vacuum and hydrogen brazing, surface treatment technologies, and other proprietary products. Ichor serves a concentrated base of original equipment manufacturers (OEMs) in the semiconductor capital equipment industry. The company operates on a 52- or 53-week fiscal year and is currently executing a Consolidation Restructuring Plan that includes exiting operations in Scotland and Korea to strengthen its operating model and expand margins. Updated

ICHR Coverage

Frequently Asked Questions

What does Ichor Holdings do?

Ichor Holdings, Ltd. (NASDAQ: ICHR) designs, engineers, and manufactures critical fluid delivery subsystems and components primarily for semiconductor capital equipment, with additional exposure to defense/aerospace and medical industries.

What is the ICHR stock price target?

The Wall Street consensus 12-month price target for ICHR is $95.86.